Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma-Reference-Cited by-同舟云学术

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma

Published:2020-09-17 Issue:12 Volume:383 Page:1139-1148
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Dummer Reinhard¹,Hauschild Axel¹,Santinami Mario¹,Atkinson Victoria¹,Mandalà Mario¹,Kirkwood John M.¹,Chiarion Sileni Vanna¹,Larkin James¹,Nyakas Marta¹,Dutriaux Caroline¹,Haydon Andrew¹,Robert Caroline¹,Mortier Laurent¹,Schachter Jacob¹,Lesimple Thierry¹,Plummer Ruth¹,Dasgupta Kohinoor¹,Gasal Eduard¹,Tan Monique¹,Long Georgina V.¹,Schadendorf Dirk¹^ORCID

Affiliation:

1. From University Hospital Zurich Skin Cancer Center, Zurich, Switzerland (R.D.); University Hospital Schleswig-Holstein, Kiel (A. Hauschild), University Hospital Essen, Essen (D.S.), and German Cancer Consortium, Heidelberg (D.S.) — all in Germany; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (M.S.), Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M.M.), and the Melanoma Oncology Unit, Veneto Oncology Institute–IRCCS, Padua (V.C.S.) — all in Italy; Princess Alexandra Hospital, Gallipoli...

Funder

Novartis Pharmaceuticals Corporation

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2005493

Cited by 306 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapy Innovations for Melanoma;Hematology/Oncology Clinics of North America;2024-10

2. Advances in Adjuvant and Neoadjuvant Therapy for Melanoma;Hematology/Oncology Clinics of North America;2024-10

3. Outcomes of adjuvant immune checkpoint inhibitor therapy in melanoma: a retrospective study;Acta Clinica Belgica;2024-09-13

4. Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma;Cancers;2024-09-06

5. Cancer cell – Fibroblast crosstalk via HB-EGF, EGFR, and MAPK signaling promotes the expression of macrophage chemo-attractants in squamous cell carcinoma;iScience;2024-09